Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%
Ph phase_1
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Other(1)

Detailed Status

Active, not recruiting1
Recruiting1
Completed1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (25.0%)
N/A3 (75.0%)

Trials by Status

active_not_recruiting125%
recruiting125%
completed125%
unknown125%

Recent Activity

2 active trials
Showing 4 of 4
active_not_recruitingnot_applicable

Randomized Trial of Prostate Only or Pelvic RT in High Risk Prostate Cancer

NCT02302105
completednot_applicable

Hypofractionated Brain Radiationcavity

NCT03561896
recruitingnot_applicable

Study of MR-based IGRT for Prostate Cancer

NCT02724670
unknownphase_1

Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma

NCT02403544

Clinical Trials (4)

Showing 4 of 4 trials
NCT02302105Not Applicable

Randomized Trial of Prostate Only or Pelvic RT in High Risk Prostate Cancer

Active Not Recruiting
NCT03561896Not Applicable

Hypofractionated Brain Radiationcavity

Completed
NCT02724670Not Applicable

Study of MR-based IGRT for Prostate Cancer

Recruiting
NCT02403544Phase 1

Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma

Unknown

All 4 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
4